SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-200068
Filing Date
2022-07-22
Accepted
2022-07-22 16:25:58
Documents
13
Period of Report
2022-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d383988d8k.htm   iXBRL 8-K 25197
  Complete submission text file 0001193125-22-200068.txt   178351

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crtx-20220720.xsd EX-101.SCH 3238
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crtx-20220720_def.xml EX-101.DEF 13401
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20220720_lab.xml EX-101.LAB 21962
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20220720_pre.xml EX-101.PRE 14199
7 EXTRACTED XBRL INSTANCE DOCUMENT d383988d8k_htm.xml XML 4975
Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38890 | Film No.: 221100189
SIC: 2836 Biological Products, (No Diagnostic Substances)